secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2023-06-23T23:59:59+00:00
Accession:  0001575872-23-001032
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

TradeUP Acquisition receives Nasdaq extension to Oct 16, 2023 for Public Holder Rule compliance
--------------------------------------------------------------------------------

- Nasdaq granted extension until October 16, 2023 to regain compliance with Listing Rule 5550(a)(3).
- Company had previously disclosed non-compliance and submitted a compliance plan on June 5, 2023.
- Failure to regain compliance by deadline may result in delisting from Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000157587223001032/0001575872-23-001032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000157587223001032/uptd-20230622.htm
  HTML page:      https://secwatch.observer/filing/0001575872-23-001032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer